Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Serum vs Artificial Tears for Isotretinoin-Induced Dry Eye
NCT02752763Phase 4Completed
- Sponsor
- Niğde State Hospital
- Start
- Oct 2015
- Primary completion
- Mar 2016
- Modality
- Biologic
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Autologous serum eye drops 20% in dry eye syndrome (DED) (2 arms), sponsored by Niğde State Hospital. Primary endpoints: Change in Schirmer Test I at 3 months, Change in Tear Break Up Time at 3 months and 1 more. Started Oct 2015; status: completed.
02
Drugs
Autologous serum eye drops 20%
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT02752763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02752763.